BackgroundThe primary aim of the study was to prepare SLS/βCD-curcumin nanosuspension and to assess its in-vivo wound healing efficacy. MethodSLS/βCD-curcumin nanosuspension was prepared based on nanoprecipitation method. Totally nine formulations were prepared to optimize various concentrations of sodium lauryl sulfate and β-cyclodextrin. Formulation FC3 with mean particle size of 206 nm, surface area of 53.4 m2/g, distribution width of 4.4 and uniformity of 0.956 was selected and carried forward for in-vivo wound healing activity in adult Wistar albino rats in comparison with control, ethanolic solution of curcumin and standard drug povidone iodine. ResultsSLS/βCD-curcumin nanosuspension and standard drug povidone iodine have shown significant (P < 0.001) percentage wound contraction in comparison with control. However, SLS/βCD-curcumin nanosuspension has produced comparable wound healing activity at about 25 times lesser dose than the standard drug povidone iodine. ConclusionsWe conclude that the prepared SLS/βCD-curcumin nanosuspension has offered significant size reduction to curcumin in nano range and contribute in enhancement of aqueous stability, solubility and reactability of curcumin at the site of wound and increased the therapeutic potency of SLS/βCD-curcumin nanosuspension in the treatment of wound.
Read full abstract